Citations

Showing 10 of 108104 citations.

Frailty Phenotypes and Relations With Surgical Outcomes: A Latent Class Analysis
Sadiq, Furqaan, Wildes, Troy S. , McKinnon, Sherry, Sharma, Anshuman , Abdallah, Arbi Ben , Kronzer, Vanessa L. , Helsten, Daniel L. , Scheier, Lawrence Matthew , Avidan, Michael Simon

Mayo Clinic

Anesthesia & Analgesia | August 15, 2018 | Volume: 127 | Issue: 4 | Pages: 1017-1027

10.1213/ane.0000000000003695 | PMID 30113393 Get It

BACKGROUND: Frailty is an important concept in the care of older adults although controversy remains regarding its defining features and clinical utility. Both the Fried phenotype and the Rockwood deficit accumulation approaches cast frailty as a “burden” without exploring the relative salience of its cardinal markers and their relevance to the patient. New multifactorial perspectives require a reliable assessment of frailty that can validly predict postoperative health outcomes. METHODS: In a retrospective study of 2828 unselected surgical patients, we used item response theory to examine the ability of 32 heterogeneous markers capturing limitations in physical, functional, emotional, and social activity domains to indicate severity of frailty as a latent continuum. Eighteen markers efficiently indicated frailty severity and were then subject to latent class analysis to derive discrete phenotypes. Next, we validated the obtained frailty phenotypes against patient-reported 30-day postoperative outcomes using multivariable logistic regression. Models were adjusted for demographics, comorbidity, type and duration of surgery, and cigarette and alcohol consumption. RESULTS: The 18 markers provided psychometric evidence of a single reliable continuum of frailty severity. Latent class analyses produced 3 distinct subtypes, based on patients’ endorsement probabilities of the frailty indicators: not frail (49.7%), moderately frail (33.5%), and severely frail (16.7%). Unlike the moderate class, severely frail endorsed emotional health problems in addition to physical burdens and functional limitations. Models adjusting for age, sex, type of anesthesia, and intraoperative factors indicated that severely frail (odds ratio, 1.89; 95% confidence interval, 1.42–2.50) and moderately frail patients (odds ratio, 1.31; 95% confidence interval, 1.03–1.67) both had higher odds of experiencing postoperative complications compared to not frail patients. In a 3-way comparison, a higher proportion of severely frail patients (10.7%) reported poorer quality of life after surgery compared to moderately frail (9.2%) and not frail (8.3%) patients ( P < .001). There was no significant difference among these groups in proportions reporting hospital readmission (5.6%, 5.1%, and 3.8%, respectively; P = .067). CONCLUSIONS: Self-report frailty items can accurately discern 3 distinct phenotypes differing in composition and their relations with surgical outcomes. Systematically assessing a wider set of domains including limitations in functional, emotional, and social activities can inform clinicians on what precipitates loss of physiological reserve and profoundly influences patients’ lives. This information can help guide the current discussion on frailty and add meaningful clinical tools to the surgical practice.
Survival and Glycemic Control in Patients With Colorectal Cancer and Diabetes Mellitus
Karlin, Nina J. , Amin, Shailja B , Buras, Matthew , Verona, Patricia M , Cook, Curtiss B. , Buras, Matthew R , Kosiorek, Heidi

Mayo Clinic

Future Science OA | August 15, 2018 | Volume: 4 | Issue: 9 | Pages: No page available

10.4155/fsoa-2018-0044 | PMID 30416744 Get It

Physiology in Perspective: The Breath of Life
Sieck, Gary C.

Mayo Clinic

Physiology | August 15, 2018 | Volume: 33 | Issue: 5 | Pages: 300-301

10.1152/physiol.00032.2018 | PMID 30109820 Get It

DNA Compression Caused by an Upstream Point Mutation
Weinshenker, Brian G. , Hebrink, David D., Gacy, A. Marquis, McMurray, Cynthia T. , Weinshenker, Brian G

Mayo Clinic

BioTechniques | August 15, 2018 | Volume: 25 | Issue: 1 | Pages: 68-72

10.2144/98251st01 | PMID 9668978 Get It

Direct Quantitation of RNA Transcripts by Competitive Single-Tube RT-PCR and Capillary Electrophoresis
Borson, Nancy D., Strausbauch, Michael, Wettstein, Peter J., Oda, R.P., Landers, James P. , Johnston, Sebastian Lennox

Mayo Clinic

BioTechniques | August 15, 2018 | Volume: 25 | Issue: 1 | Pages: 130-137

10.2144/98251rr01 | PMID 9668987 Get It

Denaturation Fingerprinting: Two Related Mutation Detection Methods Especially Advantageous for High G+C Regions
Liu, Qiang, Weinshenker, Brian G. , Wingerchuk, Dean M. , Sommer, Steve S., Weinshenker, Brian G

Mayo Clinic

BioTechniques | August 15, 2018 | Volume: 24 | Issue: 1 | Pages: 140-147

10.2144/98241rr01 | PMID 9454966 Get It

Rapid Acquisition of Unknown DNA Sequence Adjacent to a Known Segment by Multiplex Restriction Site PCR
Bolander, Mark E., Sarkar, Gobinda , WEBER, KRISTY L.

Mayo Clinic

BioTechniques | August 15, 2018 | Volume: 25 | Issue: 3 | Pages: 415-419

10.2144/98253st02 | PMID 9762438 Get It

A Narrative Review of Intensive Group Tobacco Treatment: Clinical, Research, and US Policy Recommendations
Kotsen, Chris , Santorelli, Melissa L. , Bloom, Erika Litvin , Ripley‐Moffitt, Carol , Steinberg, Michael , Burke, Michael V. , Foulds, Jonathan , Steinberg, Michael , Goldstein, Adam O

Mayo Clinic

Nicotine & Tobacco Research | August 15, 2018 | Volume: 21 | Issue: 12 | Pages: 1580-1589

10.1093/ntr/nty162 | PMID 30124924 Get It

AbstractIntroductionClinical practice guidelines recommend comprehensive treatment for tobacco dependence including pharmacotherapies and behavioral interventions. Group counseling may deliver unique treatment aspects not available with other modalities. This manuscript provides a narrative review of group treatment outcomes from real-world practice settings and complements recent meta-analyses of randomized controlled trials (RCTs). Our primary goals were to determine whether group treatments delivered in these settings have yielded similar quit rates compared to individual treatment and to provide recommendations for best practices and policy.MethodsGroup treatment was defined as occurring in a clinical or workplace setting (ie, not provided as part of a research study), led by a professionally trained clinician, and offered weekly over several weeks. English language PubMed articles from January 2000 to July 2017 were searched to identify studies that included outcomes from both group and individual treatment offered in real-world settings. Additional data sources meeting our criteria were also included. Reports not using pharmacotherapy and research studies (eg, RCTs) were excluded. The primary outcome was short-term, carbon monoxide (CO)-validated point prevalence abstinence (4-week postquit date).ResultsThe review included data from 11 observational studies. In all cases, group treatment(s) had higher 4-week CO-validated quit rates (range: 35.5%–67.3%) than individual treatment(s) (range: 18.6%–53.3%).ConclusionsBest practice group treatments for tobacco dependence are generalizable from research to clinical settings and likely to be at least as effective as intensive individual treatment. The added advantages of efficiency and cost-effectiveness can be significant. Group treatment is feasible in various settings with good results.ImplicationsA major barrier to achieving high rates of tobacco abstinence is under-utilization of evidence-based treatment interventions. This review demonstrates the effectiveness and utility of group treatment for tobacco dependence. Based on the available data described in this narrative review in conjunction with existing RCT data, group treatment for tobacco dependence should be established and available in all behavioral health and medical settings. Group tobacco treatment is now one of the mandated reimbursable tobacco treatment formats within the US health care system, creating enormous opportunities for widespread clinical reach. Finally, comprehensive worksite group programs can further extend impact.
Revision of migrated self-expandable metal stent by the remOVE device
Chua, Tiffany , Fukami, Norio

Mayo Clinic

Endoscopy | August 14, 2018 | Volume: 50 | Issue: 11 | Pages: 1129-1130

10.1055/a-0666-4462 | PMID 30107627 Get It

Next Generation Sequencing of Sporadic Vestibular Schwannoma: Necessity of Biallelic NF2 Inactivation and Implications of Accessory Non-NF2 Variants
Carlson, Matthew L. , Smadbeck, James B. , Link, Michael J., Klee, Eric W. , Vasmatzis, George , Schimmenti, Lisa A. , Schimmenti, Lisa A

Mayo Clinic

Otology & Neurotology | August 14, 2018 | Volume: 39 | Issue: 9 | Pages: e860-e871

10.1097/mao.0000000000001932 | PMID 30106846 Get It

Objectives: 1) Describe the genetic alterations discovered in a series of sporadic vestibular schwannomas (VS). 2) Identify if more clinically aggressive variants possess different genetic alterations compared to more indolent-behaving VS. Methods: Fresh frozen tumor and matched peripheral blood leukocytes from 23 individuals with sporadic VS were analyzed using whole-exome sequencing, tumor whole transcriptome expression profiling (mRNA-Seq), and tumor mate-pair analysis. Source cases included tumors with fast preoperative growth, giant tumors in young patients, tumors with macrocystic change, recurrent tumors following radiation or microsurgery, and indolent small tumors with minimal or no growth before surgery. Somatic and germ-line alterations of the NF2 gene and beyond the NF2 locus were identified and analyzed using complementing analyses. Results: Biallelic somatic events involving the NF2 gene were discovered in every analyzed tumor specimen with no concurrent NF2 variants identified in matching peripheral blood specimens. Thirteen tumors showed loss of one chromosome 22 (ch22), 4 tumors showed copy-neutral 22q loss of heterozygosity, and 31 unique small variants in the NF2 gene were discovered. Of the latter, 10 were essential splice site, 11 frame shift, 7 stop gain, 2 missense, and 1 in-frame mutation. No other common or recurring NF2 mutations were identified. However, several other notable large chromosomal aberrations were discovered including 2 tumors with loss of a chromosome 21, 3 with loss of an X or Y chromosome, 1 with copy-neutral loss of heterozygosity in chromosome 15, and 1 with loss of 18p and 16q. All of these other major chromosomal abnormalities only occurred in tumors demonstrating a more aggressive phenotype. Conclusions: To date, few studies have used whole-exome sequencing, mate-pair analysis, and RNA-seq to profile genome-wide alterations in sporadic VS. Using high-throughput deep sequencing, “two-hit” alterations in the NF2 gene were identified in every tumor and were not present in peripheral blood supporting that all events were somatic. Type of NF2 gene alteration and accessory mutations outside the NF2 locus may predict phenotypic expression and clinical course.